Esketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study
Ji-Rong Yang,Ying-Yuan Li,Tao-Jia Ran,Xiao-Yu Lin,Jin-Yan Xu,Shao-Li Zhou,Pin-Jie Huang
DOI: https://doi.org/10.2147/dddt.s460924
IF: 4.3188
2024-06-19
Drug Design Development and Therapy
Abstract:Ji-Rong Yang, 1 Ying-Yuan Li, 2 Tao-Jia Ran, 1 Xiao-Yu Lin, 1 Jin-Yan Xu, 1 Shao-Li Zhou, 1 Pin-Jie Huang 1 1 Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, People's Republic of China; 2 Department of Anesthesiology, Huadu District People's Hospital, Guangzhou, Guangdong Province, People's Republic of China Correspondence: Pin-Jie Huang; Shao-Li Zhou, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Road, Guangzhou, Guangdong Province, People's Republic of China, Email ; Purpose: We aimed to evaluate the effect of intravenous esketamine combined with dexmedetomidine as supplemental analgesia in reducing intraoperative visceral pain during elective cesarean section under combined spinal-epidural anesthesia (CSEA). Patients and Methods: A total of 269 parturients scheduled for elective cesarean section under CSEA between May 2023 and August 2023 were assessed. The parturients were randomly allocated to receiving either intravenous infusion of 0.3-mg/kg esketamine combined with 0.5-μg/kg dexmedetomidine (group ED, n=76), 0.5-μg/kg dexmedetomidine (group D, n=76), or normal saline (group C, n=76) after umbilical cord clamping. The primary outcome was intraoperative visceral pain. Secondary outcomes included the visual analog scale (VAS) score for pain evaluation and other intraoperative complications. Results: The incidence of visceral pain was lower in group ED [9 (12.7%)] than in group D [32 (43.8%)] and group C [36 (48.6%), P < 0.0001]. The VAS score was also lower in group ED when exploring abdominal cavity [0 (0), P < 0.0001] and suturing the muscle layer [0 (0), P =0.036]. The mean arterial pressure was higher in group D [83 (9) mmHg] and group ED [81 (11) mmHg] than in group C [75 (10) mmHg, P < 0.0001] after solution infusion. The heart rate after infusion of the solution was lower in group D [80 (12) bpm] than in group C [86 (14) bpm] and group ED [85 (12) bpm, P = 0.016]. The incidence of transient neurologic or mental symptoms was higher in group ED compared to group C and group D (76.1% vs 18.9% vs 23.3%, P < 0.0001). Conclusion: During cesarean section, 0.3-mg/kg esketamine combined with 0.5-μg/kg dexmedetomidine can alleviate visceral traction pain and provide stable hemodynamics. Parturients receiving this regimen may experience transient neurologic or mental symptoms that can spontaneously resolve at the end of the surgery. Plain Language Summary: Some parturients endure experience indescribable pain and discomfort during fetal delivery. Esketamine combined with dexmedetomidine can alleviate this pain during cesarean section under combined spinal-epidural anesthesia. However, after intravenous injection of esketamine and dexmedetomidine, the parturients may experience nightmares, dizziness, hallucinations, and drowsiness, etc. Keywords: cesarean section, dexmedetomidine, esketamine, CSEA, visceral pain Neuraxial anesthesia (spinal or epidural anesthesia) is the gold standard mode for cesarean section to balance the risks and benefits to both the parturient and her fetus. 1,2 However, due to partial blockage of the splanchnic nerve, some parturients experience intraoperative visceral pain, nausea, and vomiting related to peritoneal traction during fetal delivery or handling of intraperitoneal organs. 3,4 Visceral pain not only negatively affects parturients but also impacts the surgical procedure. In severe cases, it can result in adverse psychological sequelae that may lead to legal disputes. 5 Approximately one out of every 1750 parturients undergoing a cesarean section needs to be converted to general anesthesia because of insufficient neuraxial anesthesia. Additionally, 14.6% of women need additional analgesia or anesthesia. 6 Consequently, supplementary analgesics are often necessary during cesarean section performed under neuraxial anesthesia. Intrathecal or epidural opioids have been reported to be effective in preventing visceral pain during cesarean sections. 7–9 However, adverse reactions like respiratory depression, urinary retention, nausea, vomiting, and itching limit their extensive use. 10 Esketamine, a dextrorotatory isomer of ketamine, is roughly twice as potent as ketamine. 11 It has recently received widespread attention for its therapeutic effect on depression. 12,13 A randomized controlled trial has found it can reduce postpartum depression and does not cause postoperative adverse reactions. 14,15 In fact, ketamine and esketamine h -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal